Hepatitis C virus infection and cancer risk among HIV-infected individuals [1]

Infection

Volumn 31, Issue 3, 2003, Pages 194-196

  Pradier, C ^a   Piche, Marjorie ^a   Rosenthal, E ^a   Dellamonica, P ^a   Carrieri, M Patrizia ^b   Serraino, D ^c  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b INSERM   (France)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; CANCER DIAGNOSIS; CANCER RISK; COMORBIDITY; CORRELATION ANALYSIS; CRYOGLOBULINEMIA; DATA BASE; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; LETTER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; SERODIAGNOSIS; UTERINE CERVIX CANCER; VIRUS TRANSMISSION;

EID: 0038454706     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-003-3153-y     Document Type: Letter

References (15)

1. Lauer GM, Walker BD: Hepatitis C Virus Infection. N Engl J Med 2001; 345: 41-52.
2. Broers B, Junet C, Bourquin M, Degalon JI, Perrin L, Hirschel B: Prevalence and incidence rate of HIV, hepatitis B, and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. AIDS 1998; 12: 2059-2066.
3. Bonacini M, Puoti M: Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 2000; 160: 3365-3373.
4. International Agency for Research on Cancer: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 59: Hepatitis viruses. Lyon 1994.
5. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A: Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus co-infection: the Swiss HIV cohort study. Lancet 2000; 356: 1800-1805.
6. Levine AM, Nelson R, Zuckerman E, Zuckerman T, Govindarajan S, Valinluck B, Bernstein L: Lack of association between hepatitis C infection and development of AIDS-related lymphoma. J Acquir Immune Defic Syndr 1999; 20: 255-258.
7. Tirelli U, Spina M, De Paoli P, Serraino D, Carbone A: HCV and HIV-related non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 1997; 14: 80-81.
8. Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Dal Maso L, Ballarini P, Pezzotti P, Smacchia C, Pesce A, Ippolito G, Franceschi S, Rezza G: Cancer risk in men with, or at risk for, HIV infection in southern Europe. AIDS 2000; 14: 553-559.
9. Serraino D, Carrieri P, Pradier C, Bidoli E, Dorrucci M, Ghetti E, Schiesari A, Zucconi R, Pezzotti P, Dellamonica P, Franceschi S, Rezza G: Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 1999; 82: 334-337.
10. Breslow NE, Day NE: Rates and rate standardization: statistical methods in cancer research. Volume II: The design and analysis of cohort studies. IARC Sci Publ No. 82, Lyon 1987, pp 48-79.
11. International Agency for Research on Cancer: IARC monographs on the evaluation of carcinogenic risks to humans, vol. 70: Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon 1997.
12. Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE: Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk of human immunodefidency virus infection. N Engl J Med 2001; 344: 637-643.
13. Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Butto S, Lodi G, Di Carlo A, Levy JA, Ensoli B: Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998; 77: 361-365.
14. Engels EA, Frisch M, Lubin JH, Gail MH, Biggar RJ, Goedert JJ: Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin's lymphoma in AIDS. J Acquir Immune Defic Syndr 2002; 31: 536-541.
15. Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE; AIDS Clinical Trials Group 383 Study Team: Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS 2002; 16: 1915-1923.